Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Rande Is who wrote (36246)	9/25/2000 2:34:54 PM
From: Trumptown	Respond to of 57584

Alert: Anyone catch that bit on IMMU...sounded like the company denies it has been contacted by the government regarding it's drug...desparate shorts, or poor communication...any thoughts? In at $18 1/2... EDIT: here it is... <<Immunomedics (IMMU: news, msgs) shares have continued to weaken. The biopharma company just issued a statement regarding news reports of an investigation involving a former employee of the Garden State Cancer Center, where the company was conducting clinical trials. "We know of no allegations that are of merit, and in fact have not been contacted by any governmental agency regarding any such allegations," said COO Cynthia L. Sullivan>> <<Immunomedics said the trials were halted due to monitoring and record-keeping deficiencies, and not any product-related adverse events or deaths. The company expects to correct the problems and resume the trials in the near future>> www2.marketwatch.com Should be good for a couple points on the reflex rally... UTX - continues to be strong in a weak market... SR